Repeated Intravitreal Bevacizumab Injections versus Single Combined Intravitreal Bevacizumab and Posterior Subtenon Triamcinolone Injections for Treatment of Diabetic Macular Edema

References (21)

1. 1 Vascular Endothelial Growth Factor: Basic Science and Clinical Progress [DOI]
2. 2 Intravitreal triamcinolone for refractory diabetic macular edema [DOI]
3. 3 Leukocyte-Mediated Endothelial Cell Injury and Death in the Diabetic Retina [DOI]
4. 4 INTRAVITREAL BEVACIZUMAB (AVASTIN) THERAPY FOR PERSISTENT DIFFUSE DIABETIC MACULAR EDEMA [DOI]
5. 5 Intravitreal triamcinolone acetonide for diabetic diffuse macular edema11The authors have no proprietary interest in this study. 22Dr Audren, co–first author, contributed equally to the work. [DOI]
6. 6 Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema [DOI]
7. 7 Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema [DOI]
8. 8 Intraocular Pressure Elevation After Intravitreal Triamcinolone Acetonide Injection [DOI]
9. 9 Intravitreal triamcinolone acetonide and intraocular pressure [DOI]
10. 10 Vitreous Levels of Vascular Endothelial Growth Factor and Intercellular Adhesion Molecule 1 Are Related to Diabetic Macular Edema [DOI]
11. 11 Intravitreal triamcinolone for diabetic macular edema that persists after laser treatmentThree-monthefficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial [DOI]
12. 12 Caspase Activation in Retinas of Diabetic and Galactosemic Mice and Diabetic Patients [DOI]
13. 13 Comparison of Intravitreal versus Posterior Sub–Tenon’s Capsule Injection of Triamcinolone Acetonide for Diffuse Diabetic Macular Edema [DOI]
14. 14 Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema [DOI]
15. 15 Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema [DOI]
16. 16 Posterior Sub–Tenon’s Capsule Triamcinolone Injection Combined with Focal Laser Photocoagulation for Diabetic Macular Edema [DOI]
17. 17 Intravitreal versus Posterior Subtenon Injection of Triamcinolone Acetonide for Diabetic Macular Edema [DOI]
18. 18 Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema [DOI]
19. 19 Pretreatment of posterior subtenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular oedema [DOI]
20. 20 Posterior Sub-Tenon Triamcinolone for Refractory Diabetic Macular Edema: A Randomized Clinical Trial [DOI]
21. 21 A Prospective Controlled Trial to Evaluate the Adjunctive Role of Posterior Subtenon Triamcinolone in the Treatment of Diffuse Diabetic Macular Edema [DOI]

Cited by 1

Related research

• The Controversies Surrounding Bevacizumab and Ranibizumab — shares topic coverage
• Relationship of Hemoglobin A1C and Outcomes of Treatment of Diabetic Macular Edema — shares topic coverage
• Recurrent Radiation Retinopathy and Optic Neuropathy after Cranial Irradiation Therapy Treated by Intravitreal Bevacizumab — shares topic coverage
• Therapeutic Efficacy of Intravitreal Bevacizumab (Avastin)® in Patients with Parafoveal Telangiectasia Type II Complicated by Choroidal Neovascular Membrane and/or Cystoid Macular Edema — shares topic coverage
• Comparison of Visual Outcomes between Panretinal Photocoagulation and Panretinal Photocoagulation Plus Intravitreal Bevacizumab in Proliferative Diabetic Retinopathy Patients Treated at Northen Zonal Hospital — shares topic coverage